The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Spiriva 18 microgram, inhalation powder, hard capsule

18 microgram(s) Inhalation powder, hard capsule

Imbat LimitedPPA1151/018/001

Main Information

Trade NameSpiriva 18 microgram, inhalation powder, hard capsule
Active SubstancesTiotropium bromide
Strength18 microgram(s)
Dosage FormInhalation powder, hard capsule
Licence HolderImbat Limited
Licence NumberPPA1151/018/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB04 tiotropium bromide

Status

Authorised/WithdrawnAuthorised
Licence Issued27/11/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0775/002/001 only.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back